Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menopur using a threshold nomogram for ovulation induction in WHO Group II anovulatory infertility
NCT01250821Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of menotropins in anovulatory infertility, sponsored by Rigshospitalet. Primary endpoint: Proportion of patients who reach the criteria for hCG-administration within 14 days of Menopur stimulation. Started Dec 2010; status: completed.
02
Drugs
menotropins
03
Conditions
anovulatory infertility
Beyond the preview
Go deeper on NCT01250821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250821.